Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by jojomarchon Nov 05, 2017 6:48pm
123 Views
Post# 26909260

RE:RE:Need to be cashed up to finish Phase 1b

RE:RE:Need to be cashed up to finish Phase 1bI have to disagree NewdayDawning , " closer to 90 cents for FDA breakthrough or fast-track " ...no way Jose . The biotechs that get breakthrough status are valued at multiples of 90  cents . I'm under the impression that our compounds are destroying cancer cells not slowing progression like most of those highly valued immuno companies . The venture is doing a number on TLT . RW has to find a way out of this smalltime mentality . I don't mind that he might want to stay in the drivers seat but i hope he's open the communication channel with big pharma , with a 3/3  cancer free NR i know i would've been on the phone with big pharma . This science is gonna snowball .... pharmaceutical companies , doctors that specialize in oncology , investors , fund managers and , more importantly , patients afflicted with cancer that spend vast amount of time searching the internet for the best possible treatment  will all inquire about TLT . If i had cancer i would tell my doctor : " Can you get me in the trial with  the company that got the 100% cancer free results not the one with the 30% " .


GLTA
Bullboard Posts